Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer

Clinical trial NCT03999710 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03999710
Sponsor: Memorial Sloan Kettering Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Lung Cancer Nsclc NSCLC Stage II NSCLC, Stage III

Start date: 2019-07-19
Primary completion: 2027-07-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.